BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 10164326)

  • 1. Are you missing out on a valuable profit center?
    Jahn M
    Med Econ; 1997 Jan; 74(1):115-6, 119-22. PubMed ID: 10164326
    [No Abstract]   [Full Text] [Related]  

  • 2. POLs with profits, Part 1. Are you missing out on a valuable profit center?
    Jahn M
    MLO Med Lab Obs; 1997 May; 29(5):20, 58. PubMed ID: 10167463
    [No Abstract]   [Full Text] [Related]  

  • 3. You don't have to miss out on a valuable profit center. Case studies and success stories of thriving POLs.
    Jahn M
    MLO Med Lab Obs; 1997 Jul; 29(7):26, 28, 32. PubMed ID: 10170106
    [No Abstract]   [Full Text] [Related]  

  • 4. Are you missing out on a valuable profit center? Consider a physician office laboratory.
    Ruppel C
    Mich Med; 2007; 106(5):24-5. PubMed ID: 17927046
    [No Abstract]   [Full Text] [Related]  

  • 5. Stark self-referral rules burdened with complexities.
    Barratt K; Katayama A
    Wis Med J; 1995 Dec; 94(12):697-701. PubMed ID: 8571621
    [No Abstract]   [Full Text] [Related]  

  • 6. Stark rules. Purchases that pass muster.
    Terry K
    Med Econ; 2006 Dec; 83(24):44-6, 49. PubMed ID: 17249392
    [No Abstract]   [Full Text] [Related]  

  • 7. Physician refer thyself: is Stark II, phase III the final voyage?
    Manchikanti L; McMahon EB
    Pain Physician; 2007 Nov; 10(6):725-41. PubMed ID: 17987094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the impact of the new Stark rules on joint ventures.
    Washlick JR
    Healthc Financ Manage; 2008 Nov; 62(11):48-52. PubMed ID: 18990836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negotiating roadblocks to IDS-physician equity joint ventures.
    Dubow SF; Benoff M
    Healthc Financ Manage; 1998 Sep; 52(9):35-7. PubMed ID: 10182740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding new services in a medical practice.
    Beck LC
    Physician Exec; 2002; 28(6):53-5. PubMed ID: 12448145
    [No Abstract]   [Full Text] [Related]  

  • 11. Stark III: refinement not revolution (part 1).
    Gosfield AG
    Fam Pract Manag; 2008 Mar; 15(3):25-8. PubMed ID: 18422263
    [No Abstract]   [Full Text] [Related]  

  • 12. Group practice contracting with managed care: Part 2.
    Mustard LW
    J Med Pract Manage; 2003; 19(1):45-9. PubMed ID: 12971007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Stark truth about the Stark law: Part II.
    Gosfield AG
    Fam Pract Manag; 2004 Feb; 11(2):41-5. PubMed ID: 15011481
    [No Abstract]   [Full Text] [Related]  

  • 14. Determine a comfortable capitation to effectively negotiate contracts.
    Caesar N
    Manag Care; 1998 Mar; 7(3):60-1. PubMed ID: 10177963
    [No Abstract]   [Full Text] [Related]  

  • 15. Can you afford that capitation contract? Try this tool.
    Capitation Rates Data; 2003 Apr; 8(4):37-40. PubMed ID: 12722596
    [No Abstract]   [Full Text] [Related]  

  • 16. Yet more changes to the stark law regulations.
    Reisman G; Wool HS; Chananie SJ; Finnegan JH
    J Am Coll Radiol; 2009 Feb; 6(2):81-4. PubMed ID: 19179234
    [No Abstract]   [Full Text] [Related]  

  • 17. Practice management agreements: the core of the MSO-group practice alliance.
    Waxman JM
    Healthc Financ Manage; 1996 Dec; 50(12):65-8, 70. PubMed ID: 10163008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managed care and charity care: on a collision course?
    Sandrick K
    Med Netw Strategy Rep; 1999 May; 8(5):10-2. PubMed ID: 10387719
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutting red tape on clinical labs: why Congress should deregulate doctors.
    Mahkorn S
    J Ark Med Soc; 1995 Nov; 92(6):283-91. PubMed ID: 7499186
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparing your practice for capitation.
    Azevedo D
    Med Econ; 1997 Apr; 74(7):48-52, 55, 57. PubMed ID: 10165906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.